JAMA Network Home
Sign In
Original Investigation

Adoption of Adjunctive Azithromycin for Unscheduled Cesarean Delivery and Postpartum Infections

JAMA 10.1001/jama.2026.15010

September 14, 2026 at 11:00 AM EDT

Read the full article

After publication of the trial evidence in 2016, azithromycin use for pregnant persons undergoing unscheduled cesarean delivery increased and postpartum infection rates decreased in the US.

Corresponding Author: Taylor S. Freret, MD, EdM, Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, 330 Brookline Ave, Boston, MA 02115 (tfreret@bidmc.harvard.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2026.15010?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=091426

Copy to clipboard

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks